Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.37% | 171.93 | 1.3% | $497.00m | |
| BIIB | Biogen Inc. | -0.44% | 234.00 | 1.3% | $478.23m | |
| CELG | Celgene Corporation | -0.61% | 95.77 | 1.3% | $454.43m | |
| GILD | Gilead Sciences, Inc. | 0.57% | 66.88 | 0.9% | $437.21m | |
| ILMN | Illumina, Inc. | 2.08% | 312.83 | 3.5% | $317.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.81% | 317.50 | 2.6% | $296.20m | |
| A | Agilent Technologies, Inc. | -0.02% | 67.97 | 1.6% | $207.65m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.92% | 172.37 | 1.9% | $181.17m | |
| EXAS | Exact Sciences Corporation | 0.56% | 95.44 | 25.3% | $164.58m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.97% | 127.55 | 2.0% | $149.64m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.25% | 87.69 | 4.3% | $118.55m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.74% | 119.50 | 14.7% | $110.19m | |
| INCY | Incyte Corporation | 0.43% | 79.02 | 2.5% | $105.72m | |
| IONS | Ionis Pharmaceuticals, Inc. | -0.82% | 68.00 | 8.2% | $97.93m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -0.84% | 67.24 | 9.2% | $94.14m |
Company Profile
SELLAS Life Sciences Group, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the development and commercialization of novel cancer immunotherapeutics for cancer indications. Its product galinpepimut-S, or GPS, is an immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, which targets the Wilms tumor 1, or WT1, protein. Its products include galinpepimut-S and nelipepimut-S. The company was founded on April 3, 2006 and is headquartered in New York, NY.